APVO vs CPRT · $9.9M cap vs P/E 19, rev $3.51B
Aptevo Therapeutics Inc (APVO) versus Copart Inc (CPRT) — a side-by-side from cached financials, not a winner call.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Copart Inc (CPRT) is a specialty business services company listed on US.
APVO does not have a complete income-statement cache yet.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
APVO currently screens at market cap $9.9M. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Not investment advice. Open the APVO and CPRT stock pages for the full models.
Not investment advice.